동결건조 주사제 시장 규모, 점유율, 성장 분석, 약물별, 적응증별, 산업별 - 산업 예측(2023-2030년)

Global Lyophilized Injectable Drugs Market size was valued at USD 3.09 Billion in 2022 and is poised to grow from USD 3.39 Billion in 2023 to USD 5.44 Billion by 2031, at a CAGR of 6.5% during the forecast period (2024-2031).

The global market for lyophilized injectable drugs offers pharmaceutical products that have undergone freeze-drying to create stable, powder-like formulations suitable for injection. This process extends the shelf life of medications by removing water content, facilitating convenient storage and transportation. The market has experienced significant growth due to its benefits in reducing contamination risk and preserving drug efficacy. Lyophilized injectable drugs find application across various therapeutic areas such as infectious diseases, oncology, autoimmune disorders, and more. The manufacturing process involves freezing the drug solution, followed by sublimation under vacuum to obtain a dry powder that can be reconstituted into liquid form using a suitable solvent prior to administration. A key driver for the market is the demand for more stable formulations, particularly for biologics and complex molecules prone to degradation. Healthcare providers favor these drugs due to their extended shelf life, reducing wastage. Additionally, lyophilized drugs offer advantages in emergency situations and environments lacking refrigeration due to limited resources. Nevertheless, challenges such as the need for specialized equipment and higher production costs exist. Errors in reconstituting lyophilized drugs can affect medication effectiveness and patient safety, necessitating proper training and potentially wasting time and resources. Despite these obstacles, ongoing advancements in lyophilization techniques, expanding research in new therapeutic areas, and efforts to enhance drug stability are expected to sustain market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lyophilized Injectable Drugs and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Lyophilized Injectable Drugs Market Segmental Analysis

The global lyophilized injectable drugs market is segmented by Drug, Indication, Delivery, Packaging, Distribution Channel, and Region. Based on Drug the market is segmented as, Anti-infective, Anti-neoplastic, Anticoagulant, Hormones, Antiarrhythmic, Others. Based on Indication the market is segmented as, autoimmune diseases, respiratory diseases, gastrointestinal disorders, Oncology, Cardiovascular diseases, Infectious diseases, Metabolic disorders, others. Based on Delivery the market is segmented as, Prefilled diluent syringes, Multi-step devices. Based on Packaging the market is segmented as, Vials, Cartridges, and Prefilled devices. Based on Distribution Channel the market is segmented as, Hospital pharmacy, Retail pharmacy, and online pharmacy. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA).

Drivers of the Global Lyophilized Injectable Drugs Market

The rising demand for lyophilized injectable drugs is driven by the growing use of peptides, biologics, and other complex molecules in therapies. These drugs often require stable formulations to preserve their efficacy, given their delicate nature.

The process of lyophilization extends the shelf life of therapeutic drugs by removing water content and improving drug stability. Healthcare providers and pharmaceutical manufacturers seeking products with extended storage periods are particularly drawn to this advantageous characteristic.

Restraints in the Global Lyophilized Injectable Drugs Market

The rising demand for lyophilized injectable drugs is driven by the growing use of peptides, biologics, and other complex molecules in therapies. These drugs often require stable formulations to preserve their efficacy, given their delicate nature.

The process of lyophilization extends the shelf life of therapeutic drugs by removing water content and improving drug stability. Healthcare providers and pharmaceutical manufacturers seeking products with extended storage periods are particularly drawn to this advantageous characteristic.

Market Trends of the Global Lyophilized Injectable Drugs Market

Increase in Biologics and Complex Molecules: The market witnessed a rise in the development and utilization of peptides, biologics, and other complex molecules across different therapeutic areas. Lyophilization plays a crucial role in preserving the stability of these fragile molecules, ensuring their efficacy upon reconstitution, a critical factor in the industry.

Innovations in Drug Delivery: Technological advancements have led to improvements in drug delivery systems for lyophilized injectables. This includes the development of user-friendly devices and reconstitution mechanisms, enhancing patient convenience.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Lyophilized Injectable Drugs Market by Drug

• Market Overview
• Anti-infective
• Anti-neoplastic
• Anticoagulant
• Hormones
• Antiarrhythmic
• Others

Global Lyophilized Injectable Drugs Market by Indication

• Market Overview
• Autoimmune diseases
• Respiratory diseases
• Gastrointestinal disorders
• Oncology
• Cardiovascular diseases
• Infectious diseases
• Metabolic disorders
• and Others

Global Lyophilized Injectable Drugs Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vertex Pharmaceuticals Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments